凝血酶原片段F1+2(F1+2)重組蛋白
Recombinant Prothrombin Fragment 1+2 (F1+2)
- 編號RPA710Hu01
- 物種Homo sapiens (Human,人)相同的名稱,不同的物種。
- 來源原核表達(dá)
- 宿主E.coli
- 內(nèi)毒素水平<1.0EU/µg(LAL法測定)
- 亞細(xì)胞定位分泌
- 預(yù)測分子量61.5kDa
- 實(shí)際分子量50&70kDa(差異分析請參閱說明書)
- 片段與標(biāo)簽Ala44~Arg327 with N-terminal His and GST Tag
- 緩沖液成份20mM Tris, 150mM NaCl緩沖液(pH8.0, 含有1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose和Proclin300)
- 性狀凍干粉
- 純度> 97%
- 等電點(diǎn)4.6
- 應(yīng)用Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白,請參見活性蛋白。 - 下載英文說明書 中文說明書
- 規(guī)格10μg50μg200μg1mg5mg
- 價格¥ 1056 ¥ 2640¥ 5280¥ 15840¥ 39600
- 欲了解實(shí)際交易價格和更多情況,請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
序列

用法
Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復(fù)凍融。2-8°C不超過一個月,-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲,損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
編號 | 適用物種:Homo sapiens (Human,人) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) |
RPA710Hu01 | 凝血酶原片段F1+2(F1+2)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAA710Hu01 | 凝血酶原片段F1+2(F1+2)多克隆抗體 | WB; IHC; ICC; IP. |
LAA710Hu71 | 凝血酶原片段F1+2(F1+2)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
MAA710Hu22 | 凝血酶原片段F1+2(F1+2)單克隆抗體 | WB; IHC |
MAA710Hu23 | 凝血酶原片段F1+2(F1+2)單克隆抗體 | WB; IHC; ICC/IF |
MAA710Hu24 | 凝血酶原片段F1+2(F1+2)單克隆抗體 | WB; IHC |
MAA710Hu25 | 凝血酶原片段F1+2(F1+2)單克隆抗體 | WB; ICC/IF |
MAA710Hu21 | 凝血酶原片段F1+2(F1+2)單克隆抗體 | IHC |
MAA710Hu26 | 凝血酶原片段F1+2(F1+2)單克隆抗體 | WB |
FAA710Hu02 | 抗凝血酶原片段F1+2(F1+2)單克隆抗體 | Flow cytometry. |
LAA710Hu72 | 凝血酶原片段F1+2(F1+2)單克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
SEA710Hu | 凝血酶原片段F1+2(F1+2)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
HEA710Hu | 凝血酶原片段F1+2(F1+2)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法,高敏型) | Enzyme-linked immunosorbent assay for Antigen Detection. |
SCA710Hu | 凝血酶原片段F1+2(F1+2)檢測試劑盒(化學(xué)發(fā)光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. |
LMA710Hu | 凝血酶原片段F1+2(F1+2)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
PSA710Hu01 | 凝血酶原片段F1+2(F1+2)抗體對 | ELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays. |
KSA710Hu01 | 凝血酶原片段F1+2(F1+2)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗(yàn)法) | 自己動手制作ELISA試劑盒的主要材料 |
參考文獻(xiàn)
雜志 | 參考文獻(xiàn) |
Critical Care | Disseminated intravascular coagulation or acute coagulopathy of trauma shock early after trauma? An observational study[BioMed: cc10553] |
Journal of Vascular Surgery | Changes in thrombin generation, fibrinolysis, platelet and endothelial cell activity, and inflammation following endovascular abdominal aortic aneurysm repair[ScienceDirect: S0741521411018568] |
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine | High levels of soluble VEGF receptor 1 early after trauma are associated with shock, sympathoadrenal activation, glycocalyx degradation and inflammation in severely injured patients: a prospective study[Sjtrem:1757-7241] |
Journal of Thrombosis and Haemostasis | High sCD40L levels early after trauma are associated with enhanced shock, sympathoadrenal activation, tissue and endothelial damage, coagulopathy and mortality[Wiley: source] |
British Journal of Dermatology | Evaluation of autologous plasma skin test in patients with chronic idiopathic urticaria[PubMed: 21910697] |
Arteriosclerosis, Thrombosis, and Vascular Biology. | Diet Modulates Endogenous Thrombin Generation, A Biological Estimate of Thrombosis Risk, Independently of the Metabolic Status[PubMed: 22859493] |
Journal of Vascular Surgery | Medium-term effect of endovascular and open abdominal aortic aneurysm repair on thrombin generation and fibrinolysis[PubMed: 23140799] |
PLoS ONE | Markers of Thrombogenesis and Fibrinolysis and Their Relation to Inflammation and Endothelial Activation in Patients with Idiopathic Pulmonary Arterial Hypertension[Plosone: Source] |
Journal of Vascular Surgery | Effect of endovascular and open abdominal aortic aneurysm repair on thrombin generation and fibrinolysis[Pubmed: 23140799 ] |
Haemetology | Clinical impact of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations among sickle cell disease patients of Central India[Pubmed: 23992124] |
Cogent Medicine | Study the association of adiponectin with inflammation and hypercoagulability in case of type 2 diabetic subjects with renal dysfunction[Tandfonline:Source] |
Interact Cardiovasc Thorac Surg. | An ex vivo evaluation of blood coagulation and thromboresistance of two extracorporeal circuit coatings with reduced and full heparin dose[Pubmed:24632424] |
Perfusion | Ex vivo simulation of cardiopulmonary bypass with human blood for hemocompatibility testing[PubMed: 26243277] |
J Thromb Haemost | Comparison of the Effect of Dabigatran and Dalteparin on Thrombus Stability in a Murine Model of Venous Thromboembolism[PubMed: 26514101] |
Acta Oncologica Turcica | Thrombin activatable fibrinolysis inhibitor (TAFI), tissue factor pathway inhibitor (TFPI), and prothrombin fragment 1+2 levels in patients with advanced colorectal cancer [aot:AOT_49_1_6_12.pdf] |
Advances in Medical Sciences | Perioperative thrombocytopenia predicts poor outcome in patients undergoing transcatheter aortic valve implantation[pubmed:29145170] |
Thrombosis Research | The causes of thrombocytopenia after transcatheter aortic valve implantation[pubmed:28582640] |
Acta?Haematologica | Elevations of Thrombotic Biomarkers in Hemoglobin H Disease[Pubmed:29402840] |
Journal of Neurotrauma | The cerebral thrombin system is activated after intracerebral hemorrhage and contributes to secondary lesion growth and poor neurological outcome in C57Bl/6 mice[Pubmed: 31830857] |
Indian Journal of Public Health Research & Development | Enhanced Fibrin-Lysis in Grade-1 Dengue Haemorrhagic Fever[] |
Rheumatol Int | The impact of anti-endothelial cell antibodies (AECAs) on the development of blood vessel damage in patients with systemic lupus erythematosus: the preliminary?…[Pubmed:35284968] |